WCLC News
-
Know Before You Go: What You Need to Know to Get to—and Navigate—San Diego
With the 2024 World Conference on Lung Cancer less than a month away, now is the time to make sure you know where you’re headed and how to get there.
-
Multidisciplinary Team to Chair 2025 World Conference
Drs. Umberto Malapelle, Jarushka Naidoo, Isabelle Opitz, and Noemí Reguart will lead WCLC when it returns to Barcelona September 6-9, 2025.
-
Data Support IMRT as Standard of Care for Locally Advanced NSCLC
During the 2023 World Conference on Lung Cancer, Dr. Stephen Chun said long-term data show intensity-modulated radiation therapy offers an overall survival benefit and reduced toxicity compared to 3D conformal radiation therapy.
-
Media Training Improves Advocacy Reach, Increases Lung Cancer Awareness
LungCAN Co-Chair Dusty Donaldson says training program helped just two advocates reach more than 630 million people in 32 states and five countries.
-
Experts Highlight Advances in Lung Cancer Pathology During World Conference Closing Plenary Session
Drs. Keith Kerr and Sanja Dacic shared findings from the IASLC Pathology Committee, which is investigating how to best assess pathologic response to neoadjuvant immunotherapy in lung cancer.
-
Data Show Certain Reproductive Factors Are Associated with Increased Risk of Lung Cancer in Women
During WCLC 2023, Dr. Yan Zhang presented findings that she says support the inclusion of factors such as early menarche and early menopause in lung cancer screening programs.
-
WCLC Plenary Session Featured Lectureship Award Winners Discussing Range of Issues in Thoracic Oncology
Drs. Wendy Cooper, Melissa Culligan, And Navneet Singh concluded the session with talks on the future of pathology, enhancing the patient experience, and accurate staging in lung cancer.
-
Middle East and Africa Region Earns Bragging Rights with Most Points During 2023 Wellness Challenge
The challenge, Step It Up for Research, helped WCLC 23 attendees stay active during the meeting while raising money to support the IASLC Foundation, which provides grants for research, education, and other scientific initiatives.
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura and Drs. Valerie Rusch and Enrico Ruffini summarized the data and recommendations in lung cancer, mesothelioma, and thymic cancer.
-
AEGEAN Shows Benefit with the Addition of Perioperative Durvalumab to Neoadjuvant Chemotherapy in Resectable NSCLC
Dr. Tetsuya Mitsudomi, who presented the data at WCLC 2023, said regardless of disease stage, the addition of perioperative durvalumab did not adversely impact the feasibility, type, approach, or timing of surgery for participants in the trial.
View ILCN Archives
Provider Resources